BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 8496876)

  • 21. Limitation of serological testing for Lyme borreliosis: evaluation of ELISA and western blot in comparison with PCR and culture methods.
    Tylewska-Wierzbanowska S; Chmielewski T
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):601-5. PubMed ID: 12422608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroconversion to Borrelia burgdorferi in a patient with juvenile arthritis in Ontario, Canada.
    Laxer RM; Artsob H
    J Rheumatol; 1988 Oct; 15(10):1580-2. PubMed ID: 3204603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and serological features of patients with suspected Lyme borreliosis.
    Santino I; Longobardi V
    Int J Immunopathol Pharmacol; 2011; 24(3):797-801. PubMed ID: 21978712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The outcome of Lyme borreliosis in children.
    Aberer E; Kehldorfer M; Binder B; Schauperi H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):941-4. PubMed ID: 10666805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Laboratory diagnosis of Lyme borreliosis].
    Hoogkamp-Korstanje JA
    Ned Tijdschr Geneeskd; 1997 Nov; 141(48):2339-42. PubMed ID: 9550824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The polymerase chain reaction evaluation of Borrelia burgdorferi DNA presence in peripheral blood of patients with Lyme disease].
    Kondrusik M; Grygorczuk S; Skotarczak B; Wodecka B; Pancewicz S; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T
    Pol Merkur Lekarski; 2004 Dec; 17(102):593-6. PubMed ID: 15771130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of Lyme disease.
    DePietropaolo DL; Powers JH; Gill JM; Foy AJ
    Del Med J; 2006 Jan; 78(1):11-8. PubMed ID: 16548394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual serologic reactivity in children with resolved Lyme arthritis.
    Rose CD; Fawcett PT; Gibney KM; Doughty RA
    J Rheumatol; 1996 Feb; 23(2):367-9. PubMed ID: 8882048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibodies against Borrelia garinii in diagnosis of Lyme disease].
    Flisiak R; Prokopowicz D
    Przegl Lek; 2000; 57(3):147-9. PubMed ID: 10909283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. False positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: the value of immunoblot analysis.
    Weiss NL; Sadock VA; Sigal LH; Phillips M; Merryman PF; Abramson SB
    Lupus; 1995 Apr; 4(2):131-7. PubMed ID: 7795616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The significance of immunoblot tests in diagnosis of Lyme borreliosis in children].
    Ołdak E; Sulik A; Rozkiewicz D
    Przegl Epidemiol; 2008; 62 Suppl 1():83-7. PubMed ID: 22320040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of Borrelia burgdorferi sensu lato DNA by PCR in serum of patients with clinical symptoms of Lyme borreliosis.
    Santino I; Berlutti F; Pantanella F; Sessa R; del Piano M
    FEMS Microbiol Lett; 2008 Jun; 283(1):30-5. PubMed ID: 18384365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [False positive serological test in suspected borreliosis].
    Ulvestad E; Kristoffersen EK
    Tidsskr Nor Laegeforen; 2002 Jan; 122(1):88-90. PubMed ID: 11851307
    [No Abstract]   [Full Text] [Related]  

  • 34. Serological distinction between syphilis and Lyme borreliosis.
    Rath PM; Marsch WC; Brade V; Fehrenbach F
    Zentralbl Bakteriol; 1994 Jan; 280(3):319-24. PubMed ID: 8167425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A limitation of 2-stage serological testing for Lyme disease: enzyme immunoassay and immunoblot assay are not independent tests.
    Wormser GP; Carbonaro C; Miller S; Nowakowski J; Nadelman RB; Sivak S; Aguero-Rosenfeld ME
    Clin Infect Dis; 2000 Mar; 30(3):545-8. PubMed ID: 10722442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feedback on difficulties raised by the interpretation of serological tests for the diagnosis of Lyme disease.
    Hansmann Y; Leyer C; Lefebvre N; Revest M; Rabaud C; Alfandari S; Christmann D; Tattevin P
    Med Mal Infect; 2014 May; 44(5):199-205. PubMed ID: 24794819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area.
    Nyman D; Willén L; Jansson C; Carlsson SA; Granlund H; Wahlberg P
    Clin Microbiol Infect; 2006 May; 12(5):496-7. PubMed ID: 16643532
    [No Abstract]   [Full Text] [Related]  

  • 38. The laboratory diagnosis of ocular Lyme borreliosis.
    Mikkilä H; Karma A; Viljanen M; Seppälä I
    Graefes Arch Clin Exp Ophthalmol; 1999 Mar; 237(3):225-30. PubMed ID: 10090586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of two gene species in the serological diagnosis of Borrelia burgdorferi infections].
    Gutiérrez J; Núñez F; Piédrola G; Maroto C
    Rev Med Chil; 1998 Jun; 126(6):629-36. PubMed ID: 9778870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiologic, ecologic and clinical characteristics of Lyme borrelliosis in northwest Croatia.
    Golubić D; Rijpkema S; Tkalec-Makovec N; Ruzić E
    Acta Med Croatica; 1998; 52(1):7-13. PubMed ID: 9599811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.